Literature DB >> 23142946

Potassium channels: a review of broadening therapeutic possibilities for neurological diseases.

Snezana Maljevic1, Holger Lerche.   

Abstract

Potassium (K(+)) channels are encoded by approximately 80 genes in mammals. They are expressed in many tissues and have diverse physiological roles. Human K(+) channels are divided mainly into calcium (Ca(2+))-activated (K(Ca)), inward-rectifying (K(IR)), two-pore (K(2P)), and voltage-gated (K(v)) channels. The K(v) channels form the largest family, with approximately 40 genes. Owing to their involvement in many diseases and their specific expression patterns and physiological roles, K(+) channels present an attractive target for the development of new therapies. This review summarizes the physiological and pathophysiological roles of various potassium channels with respect to their therapeutic potential for disorders with a disturbed neuronal excitability such as epilepsy, migraine, neuropathic pain, or stroke.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142946     DOI: 10.1007/s00415-012-6727-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  82 in total

1.  Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission.

Authors:  James F Otto; Matthew M Kimball; Karen S Wilcox
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

Review 2.  Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS.

Authors:  Henrik H Hansen; Olivier Waroux; Vincent Seutin; Thomas J Jentsch; Susana Aznar; Jens D Mikkelsen
Journal:  J Physiol       Date:  2008-01-03       Impact factor: 5.182

Review 3.  Localization and targeting of voltage-dependent ion channels in mammalian central neurons.

Authors:  Helene Vacher; Durga P Mohapatra; James S Trimmer
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

4.  Inhibition of large-conductance calcium-activated potassium channel by 2-methoxyestradiol in cultured vascular endothelial (HUV-EC-C) cells.

Authors:  H T Chiang; S N Wu
Journal:  J Membr Biol       Date:  2001-08-01       Impact factor: 1.843

Review 5.  Potassium channels: molecular defects, diseases, and therapeutic opportunities.

Authors:  C C Shieh; M Coghlan; J P Sullivan; M Gopalakrishnan
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

6.  Acquired dendritic channelopathy in temporal lobe epilepsy.

Authors:  Christophe Bernard; Anne Anderson; Albert Becker; Nicholas P Poolos; Heinz Beck; Daniel Johnston
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

7.  KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes.

Authors:  B A Neubauer; S Waldegger; J Heinzinger; A Hahn; G Kurlemann; B Fiedler; F Eberhard; H Muhle; U Stephani; S Garkisch; O Eeg-Olofsson; U Müller; T Sander
Journal:  Neurology       Date:  2008-07-15       Impact factor: 9.910

Review 8.  Nervous system KV7 disorders: breakdown of a subthreshold brake.

Authors:  Snezana Maljevic; Thomas V Wuttke; Holger Lerche
Journal:  J Physiol       Date:  2008-01-31       Impact factor: 5.182

9.  Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells.

Authors:  Sheng-Nan Wu; Shiuh-Inn Liu; Mei-Han Huang
Journal:  Endocrinology       Date:  2003-11-26       Impact factor: 4.736

Review 10.  Therapeutic potential of neuronal two-pore domain potassium-channel modulators.

Authors:  Alistair Mathie; Emma L Veale
Journal:  Curr Opin Investig Drugs       Date:  2007-07
View more
  26 in total

1.  Developmental nicotine exposure alters potassium currents in hypoglossal motoneurons of neonatal rat.

Authors:  Marina Cholanian; Jesse Wealing; Richard B Levine; Ralph F Fregosi
Journal:  J Neurophysiol       Date:  2017-02-01       Impact factor: 2.714

Review 2.  Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission.

Authors:  Olivier Roca-Lapirot; Houda Radwani; Franck Aby; Frédéric Nagy; Marc Landry; Pascal Fossat
Journal:  Br J Pharmacol       Date:  2017-03-24       Impact factor: 8.739

Review 3.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

Review 4.  Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.

Authors:  Jennifer A Rinker; Patrick J Mulholland
Journal:  Pharmacogenomics       Date:  2017-03-27       Impact factor: 2.533

Review 5.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

6.  Ion channels and pain: important steps towards validating a new therapeutic target for neuropathic pain.

Authors:  James S Trimmer
Journal:  Exp Neurol       Date:  2014-02-05       Impact factor: 5.330

Review 7.  Regulating excitability of peripheral afferents: emerging ion channel targets.

Authors:  Stephen G Waxman; Gerald W Zamponi
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

Review 8.  Variants in Ion Channel Genes Link Phenotypic Features of Bipolar Illness to Specific Neurobiological Process Domains.

Authors:  Yokesh Balaraman; Debomoy K Lahiri; John I Nurnberger
Journal:  Mol Neuropsychiatry       Date:  2015-02-20

9.  Rhodol-based thallium sensors for cellular imaging of potassium channel activity.

Authors:  Brendan F Dutter; Anna Ender; Gary A Sulikowski; C David Weaver
Journal:  Org Biomol Chem       Date:  2018-08-08       Impact factor: 3.876

Review 10.  Targeting BKCa Channels in Migraine: Rationale and Perspectives.

Authors:  Mohammad Al-Mahdi Al-Karagholi; Christian Gram; Cherie Amalie Waldorff Nielsen; Messoud Ashina
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.